Nociscan Technology Gains Traction at London Clinic for Chronic Back Pain Diagnosis

Aclarion, Inc., a commercial-stage healthcare technology company, has released a new video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon at The London Clinic, discussing his clinical experience with the Nociscan diagnostic tool. The video highlights the growing integration of this technology into routine practice at one of the United Kingdom’s leading private hospitals. To date, nearly 100 Nociscans have been conducted at The London Clinic, indicating sustained physician engagement with the technology.

Nociscan is a non-invasive solution that helps physicians differentiate between painful and non-painful discs in the lumbar spine by leveraging MR spectroscopy and proprietary signal processing to identify chemical biomarkers associated with disc pain. Mr. Sutcliffe, who also serves as Lead Clinician at The London Spine Clinic, noted that the technology provides valuable additional insight. ‘Nociscan provides an additional layer of insight that complements traditional imaging,’ said Mr. Sutcliffe. ‘Having more objective data can help inform clinical decisions and improve confidence when evaluating patients with chronic low back pain.’

The clinical significance of this adoption is substantial given the global burden of chronic low back pain, which affects approximately 266 million people worldwide. When used alongside other diagnostic tools, clinical data has demonstrated up to a 97% surgical success rate when all Nociscan-positive discs are treated. Brent Ness, Chief Executive Officer of Aclarion, emphasized the importance of this milestone. ‘This video offers a compelling perspective on how Nociscan is being used in day-to-day clinical practice,’ said Ness. ‘Approaching 100 scans at a leading international center like The London Clinic is an important indicator of increasing adoption and reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain.’

The technology represents an advancement in addressing a significant healthcare challenge by providing physicians with more objective data to guide treatment decisions. For more information on Nociscan, physicians can visit www.aclarion.com to learn about the evidence-supported SaaS platform. The continued utilization at The London Clinic suggests that Nociscan is gaining acceptance as a complementary diagnostic tool in spinal care, potentially improving outcomes for patients suffering from chronic low back pain through more precise identification of pain sources.

This news story relied on content distributed by PRISM Mediawire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Nociscan Technology Gains Traction at London Clinic for Chronic Back Pain Diagnosis.

The post Nociscan Technology Gains Traction at London Clinic for Chronic Back Pain Diagnosis appeared first on citybuzz.